Zobrazeno 1 - 10
of 1 076
pro vyhledávání: '"Einarson, T.R."'
Autor:
Lemos, E.V. *, de la Hoz, F.P., Einarson, T.R., McGhan, W.F., Quevedo, E., Castañeda, C., Kawai, K.
Publikováno v:
In Clinical Microbiology and Infection May 2014 20(5):416-423
Autor:
Lemos, E.V., de la Hoz, F.P., Alvis, N., Einarson, T.R., Quevedo, E., Castañeda, C., Leon, Y., Amado, C., Cañon, O., Kawai, K.
Publikováno v:
In Clinical Microbiology and Infection February 2014 20(2):174-180
Autor:
Evans, Anthony J.1 (AUTHOR) antevans@unmc.edu, Li, Yu-Long1,2 (AUTHOR) yulongli@unmc.edu
Publikováno v:
International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p12464. 28p.
Autor:
Ha, Yong Hyun1 (AUTHOR) hayo119@naver.com, Sung, Jung Hoon2 (AUTHOR) atropin5@cha.ac.kr, Ryu, Chang Soo1 (AUTHOR) regis2040@nate.com, Ko, Eun Ju1 (AUTHOR) ejko05@naver.com, Park, Hyeon Woo1 (AUTHOR) aabb1114@naver.com, Park, Han Sung1 (AUTHOR) hahnsung@naver.com, Kim, Ok Joon3 (AUTHOR) okjun77@cha.ac.kr, Kim, In Jai2 (AUTHOR) injaikim@cha.ac.kr, Kim, Nam Keun1 (AUTHOR) injaikim@cha.ac.kr
Publikováno v:
International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 21, p11528. 12p.
Autor:
Ziani, Federico1 (AUTHOR) f.ziani@studenti.uniss.it, Tettamanzi, Matilde1 (AUTHOR) g.arrica@studenti.uniss.it, Arrica, Giovanni1 (AUTHOR) e.filigheddu@studenti.uniss.it, Cuomo, Roberto2 (AUTHOR) robertocuomo@outlook.com, Filigheddu, Edoardo1 (AUTHOR) corubino@uniss.it, Trignano, Claudia3 (AUTHOR) ctrignano@uniss.it, Liperi, Corrado4 (AUTHOR) corrado.liperi@aouss.it, Rubino, Corrado1,5 (AUTHOR) etrignano@uniss.it, Trignano, Emilio1,5 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Oct2024, Vol. 13 Issue 20, p6057. 11p.
Autor:
Ptaszek, Bartłomiej1 (AUTHOR) bartlomiej.ptaszek@awf.krakow.pl, Wójciak, Anna2 (AUTHOR), Żak, Angelika2 (AUTHOR), Podsiadło, Szymon3 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Oct2024, Vol. 13 Issue 19, p5743. 13p.
Autor:
Iskedjian, M.1, Einarson, T.R.2
Publikováno v:
Clinical Drug Investigation. 1998, Vol. 16 Issue 1, p9-18. 10p.
Publikováno v:
In Value in Health October 2018 21 Supplement 3:S114-S114
Background: Patients having chronic schizophrenia with frequent relapses and hospitalizations represent a great challenge, both clinically and financially. Risperidone long-acting injection (RIS-LAI) has been the main LAI atypical antipsychotic treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::1ccb37b4796a0f5cd69f4e090abc7113
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3111081
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3111081
Autor:
Mirnic, Jelena1 (AUTHOR) jelena.mirnic@mf.uns.ac.rs, Djuric, Milanko2 (AUTHOR) milanko.djuric@mf.uns.ac.rs, Brkic, Snezana3 (AUTHOR) snezana.brkic@mf.uns.ac.rs, Gusic, Ivana2 (AUTHOR) ivana.gusic@mf.uns.ac.rs, Stojilkovic, Marija1 (AUTHOR) tanja.veljovic@mf.uns.ac.rs, Tadic, Ana2 (AUTHOR) ana.tadic@mf.uns.ac.rs, Veljovic, Tanja1 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 18, p9806. 17p.